The board of directors at Vallon Pharmaceuticals has a history of experience in the synthetic organic chemistry industry, with members having worked as the founder, president, and CEO of Arcturus Therapeutics, as well as a senior manager and scientist at Nitto Denko and Kalypsys, respectively. All members of the board have received education from the University of Calgary in synthetic organic chemistry.
View all